Michael Koslowski
53Patents
11h-index
34Co-inventors
74Inventor score
Filing activity: Mar 12, 2003 → Dec 30, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7527933B2 | Genetic products differentially expressed in tumors and the use thereof | Chemistry; Metallurgy | 100 | Expired |
| US8946388B2 | Monoclonal antibodies for treatment of cancer | Chemistry; Metallurgy | 38 | Active |
| US10738355B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 35 | Active |
| US8586047B2 | Genetic products differentially expressed in tumors and the use thereof | Chemistry; Metallurgy | 19 | Active |
| US8637012B2 | Genetic products differentially expressed in tumors and the use thereof | Chemistry; Metallurgy | 18 | Active |
| US9044382B2 | Genetic products differentially expressed in tumors and the use thereof | Chemistry; Metallurgy | 17 | Active |
| US8088588B2 | Genetic products differentially expressed in tumors and the use of thereof | Chemistry; Metallurgy | 17 | Active |
| US9487584B2 | Antibodies specific for claudin 6 (CLDN6) | Chemistry; Metallurgy | 14 | Active |
| US9718886B2 | Cancer therapy using CLDN6 target-directed antibodies in vivo | Chemistry; Metallurgy | 12 | Active |
| US9321842B2 | Antibodies for treatment of cancer | Chemistry; Metallurgy | 12 | Active |
| US7785801B2 | Identification of surface-associated antigens for tumor diagnosis and therapy | Physics | 11 | Expired |
| US9216218B2 | Monoclonal antibodies for treatment of cancer | Chemistry; Metallurgy | 10 | Active |
| US9175088B2 | Identification of tumor-associated markers for diagnosing or monitoring ovarian cancer | Chemistry; Metallurgy | 8 | Active |
| US9533043B2 | Identification of surface-associated antigens for tumor diagnosis and therapy | Physics | 7 | Active |
| US9194004B2 | Identification of surface-associated antigens for tumor diagnosis and therapy | Chemistry; Metallurgy | 6 | Active |
| US9255131B2 | Identification of surface-associated antigens for tumor diagnosis and therapy | Physics | 5 | Active |
| US9775785B2 | Antibody to genetic products differentially expressed in tumors and the use thereof | Chemistry; Metallurgy | 5 | Active |
| US8961980B2 | Monoclonal antibodies for treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US8975375B2 | Identification of tumor-associated antigens for diagnosis and therapy | Chemistry; Metallurgy | 4 | Active |
| US8354104B2 | Monoclonal antibodies for treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US9475867B2 | Monoclonal antibodies for treatment of cancer | Chemistry; Metallurgy | 3 | Active |
| US10233253B2 | Antibodies for treatment of cancer expressing claudin 6 | Chemistry; Metallurgy | 3 | Active |
| US9090940B2 | Identification of surface-associated antigens for tumor diagnosis and therapy | Chemistry; Metallurgy | 2 | Active |
| US11248264B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US9637548B2 | Methods and compositions for diagnosis and treatment of cancer | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.